Trials Annotator

Status: Withdrawn Suspended Terminated

Trial	Updated / Type	Phase	Were Results Reported	Reported Actual Enrollment	(MeSH) Terms	Why Stopped Limitations And Caveats
NCT00855062 Details	2011-02-25 Interventional	1/2		73	Minocycline Cognitive Dysfu… HIV Infections HIV-associated …	The Neurologic AIDS Research Consortium Data Safety and Monitoring Board committee recommended to terminate the study early due to futility on 11/6/2009. The estimated sample size was 100; however, due to early termination of the study, the total number of randomized participants was 73.
NCT00150085 Details	2011-02-18 Interventional	4		50	Cyclosporine Cyclosporins Tacrolimus-asso…	- -
NCT00552578 Details	2011-02-17 Interventional	4	[1 Refs]	12	Buprenorphine Buprenorphine, … Naloxone Opioid-Related … Pain, Intractab… Opiate Addictio… Refractory Pain	"Tapering doses" protocol arm was not effective for treatment retention outcome. -
NCT00637962 2007-000781-20 2007-000781-20 Details	2011-02-11 Interventional	1		23	polysaccharide-… Acquired Immuno… HIV Infections Immunologic Def… Acquired Immune…	IMP expired prior to completion of recruitment -
NCT00473616 Details	2011-02-11 Interventional	1		-	Irinotecan Neoplasms Advanced Solid … Advanced Solid … Cancer	Termination of the study was made after a full review of program data and assessment of the current risk-benefit profile. -
NCT00937664 Details	2011-02-07 Interventional	1		24	Gemcitabine Neoplasms Advanced Solid … Cancer Solid Tumors	Termination of the study was made after a full review of program data and assessment of the current risk-benefit profile. -
NCT01140412 Details	2011-02-04 Interventional	1		14	Fosamprenavir Maraviroc Ritonavir Healthy	The trial prematurely terminated on November 1, 2010, due to healthy volunteer participants experiencing non-serious fosamprenavir-related skin rash. -
NCT01034410 Details	2011-02-02 Interventional	2		-	Cytarabine Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L…	- -
NCT01286090 Details	2011-01-31 Interventional	4		4	Cisapride Diabetes Mellit… Gastroparesis	Sponsor request -
NCT00252811 Details	2011-01-28 Interventional	2		-	Gefitinib Breast Neoplasm… Breast Cancer	- -
NCT00233636 Details	2011-01-27 Interventional	2		-	Gefitinib Carcinoma Carcinoma, Squa… Head and Neck C…	- -
NCT00233623 Details	2011-01-27 Interventional	2		-	Fluorouracil Gefitinib Irinotecan Leucovorin Colorectal Neop… Metastatic Colo…	- -
NCT00405808 2006-001711-30 Details	2011-01-26 Interventional	3		2666	Rimonabant Obesity	EMEA recommendation to suspend Acomplia marketing authorisation -
NCT00065117 Details	2011-01-26 Interventional	2		-	Fluorouracil Leucovorin Oxaliplatin Colorectal Neop… Neoplasm Metast… Neoplasms Metastases, Neo…	- -
NCT01282879 Details	2011-01-25 Interventional	4	[2 Refs]	36	Itraconazole Graft vs Host D… Invasive Fungal…	In interim analysis, this study met the primary hypothesis. -
NCT01281566 Details	2011-01-24 Interventional	4		8	Cisapride Premature Birth Infant, Newborn Infant, Prematu…	Sponsor request -
NCT01281553 Details	2011-01-24 Interventional	4		6	Cisapride Gastroesophagea…	Sponsor request -
NCT01281540 Details	2011-01-24 Interventional	4		20	Cisapride Gastroparesis	Sponsor request -
NCT00577356 Details	2011-01-20 Interventional	2		6	Docetaxel Prostatic Neopl… Prostate Cancer	Safety reasons, though no safety issues arose. the trial was closed prior to planned accrual of 30 patients due to an external report from the randomized trial of docetaxel and CG1940/CG8711 resulting in a higher incidence of deaths compared to docetaxel alone in metastatic prostate cancer.
NCT00003113 Details	2011-01-17 Interventional	2		6	Cyclophosphamid… Etoposide Lomustine Procarbazine Lymphoma Lymphoma, Non-H…	- -

Filter:

7805 Trials matched filter criteria